CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $37,000 | -48.6% | 85,442 | -4.5% | 0.00% | – |
| Q1 2017 | $72,000 | +16.1% | 89,463 | +0.6% | 0.00% | – |
| Q4 2016 | $62,000 | -31.1% | 88,917 | +0.4% | 0.00% | – |
| Q3 2016 | $90,000 | -51.9% | 88,553 | +0.1% | 0.00% | – |
| Q2 2016 | $187,000 | -21.8% | 88,462 | 0.0% | 0.00% | – |
| Q1 2016 | $239,000 | -3.2% | 88,462 | -0.1% | 0.00% | – |
| Q4 2015 | $247,000 | -23.5% | 88,553 | +0.2% | 0.00% | – |
| Q3 2015 | $323,000 | -20.2% | 88,371 | +0.2% | 0.00% | – |
| Q2 2015 | $405,000 | +15.1% | 88,189 | +125.1% | 0.00% | – |
| Q1 2015 | $352,000 | +127.1% | 39,169 | +56.6% | 0.00% | – |
| Q4 2014 | $155,000 | +96.2% | 25,014 | +32.5% | 0.00% | – |
| Q3 2014 | $79,000 | – | 18,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $8,909,000 | 8.51% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,895,000 | 7.33% |
| Rock Springs Capital Management LP | 625,000 | $1,694,000 | 0.14% |
| Deer VII & Co. Ltd. | 166,675 | $452,000 | 0.12% |
| Granahan Investment Management | 730,015 | $1,978,000 | 0.07% |
| Northeast Financial Consultants Inc | 20,000 | $54,000 | 0.03% |
| Donald L. Hagan, LLC | 3,900 | $11,000 | 0.01% |
| Alyeska Investment Group, L.P. | 312,809 | $848,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $43,000 | 0.01% |
| TFS CAPITAL LLC | 15,895 | $43,000 | 0.01% |